CD21 positive B cell: a novel target for treatment of multiple sclerosis.

Farjam, Mojtaba

CD21 positive B cell: a novel target for treatment of multiple sclerosis. [electronic resource] - Medical hypotheses May 2013 - 556-7 p. digital

Publication Type: Journal Article

1532-2777

10.1016/j.mehy.2013.01.016 doi


Anti-Inflammatory Agents--therapeutic use
B-Lymphocytes--drug effects
Epstein-Barr Virus Infections--drug therapy
Humans
Models, Immunological
Multiple Sclerosis--drug therapy
Receptors, Complement 3d--antagonists & inhibitors